| Literature DB >> 25841653 |
Pawel Borun1, Marina De Rosa, Boguslaw Nedoszytko, Jaroslaw Walkowiak, Andrzej Plawski.
Abstract
Peutz-Jeghers syndrome (PJS) is a rare hereditary syndrome characterized by the occurrence of hamartomatous polyps in the gastrointestinal tract, mucocutaneous pigmentation and increased risk of cancer in multiple internal organs. PJS is preconditioned by the manifestation of mutations in the STK11 gene. The majority of detected STK11 changes are small scale mutations, however recent studies showed the significant contribution of medium-sized changes commonly known as copy number variations (CNVs). Here we present a novel 7001 bps deletion of STK11 gene fragment, in which we identified the presence of breakpoints (BPs) within the Alu elements. Comparative meta-analysis with the 80 other CNV cases from 12 publications describing STK11 mutations in patients with PJS revealed the participation of specific Alu elements in all deletions of exons 2-3 so far described. Moreover, we have shown their involvement in the two other CNVs, deletion of exon 2 and deletion of exon 1-3 respectively. Deletion of exons 2-3 of the STK11 gene may prove to be the most recurrent large rearrangement causing PJS. In addition, the sequences present in its BPs may be involved in a formation of a significant percentage of the remaining gene CNVs. This gives a new insight into the conditioning of this rare disease and enables improvements in PJS genetic diagnostics.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25841653 PMCID: PMC4559094 DOI: 10.1007/s10689-015-9800-5
Source DB: PubMed Journal: Fam Cancer ISSN: 1389-9600 Impact factor: 2.375
Summary of the STK11 gene exons 2–3 deletions in other populations
| Study | Original mutation description | Mutation size | Distal BP (5′) | Proximal BP (3′) | Interspersed repeat at 5′ BP | Interspersed repeat at 3′ BP |
|---|---|---|---|---|---|---|
| Our study | c.280 + 5594_464 + 384del7001 | 7001 | 1,212,796 | 1,219,796 | AluY(1) | AluY(3) |
| Chile [ | 1,213,168–1,219,550 | 6383 (6364 according to the authors) | 1,213,168 | 1,219,550 | AluY(2) | AluY(3) |
| Italy II [ | 1,164,146–1,164,152 1,170,695–1,170,701 | 6549 | 1,213,146–1,213,152 | 1,219,695–1,219,701 | AluY(2) | AluY(3) |
| Italy II [ | 1,164,240–1,164,248 1,170,788–1,170,796 | 6548 | 1,213,240–1,213,248 | 1,219,788–1,219,796 | AluY(2) | AluY(3) |
| Italy I [ | NC_000019.8:g.6998_13998del (7 KB del. spanning exons 2–3) p.E98_G115del | 7000 | 1,212,795 | 1,219,795 | AluY(1) | AluY(3) |
| Hungary [ | c.291-5484_464 + 384del6865 | 6865 | 1,212,932 | 1,219,796 | FLAM_C (between AluY(1) and AluY(2) | AluY(3) |
| Germany [ | c.291-?_464 + ?del | No data | No data | No data | No data | No data |
| Korea [ | – | No data | No data | No data | No data | No data |
| UK [ | c.333-?_424 + ?del | No data | No data | No data | No data | No data |
| Netherlands [ | – | No data | No data | No data | No data | No data |
| Australia [ | – | No data | No data | No data | No data | No data |
| Australia [ | – | No data | No data | No data | No data | No data |
Summary of other CNVs with the involvement of Alu elements of interest in the STK11 gene
| Study | Original mutation description | Deleted exons | Mutation size | Distal BP (5′) | Proximal BP (3′) | Interspersed repeat at 5′ BP | Interspersed repeat at 3′ BP |
|---|---|---|---|---|---|---|---|
| Italy II [ | 1,155,146–1,155,173 1,170,719–1,170,746 | Exon 1–3 | 15,572 | 1,204,146–1,204,173 | 1,219,719–1,219,746 | AluSq | AluY(3) |
| Chile [ | 1,213,086–1,218,902 | Exon 2 | 5816 | 1,213,086 | 1,218,902 | AluY(2) | None |
Fig. 1Approximate location of each STK11 exons 2–3 deletion with identified breakpoint positions. Mutation order corresponds to the description in Table 1
Summary of clinical data of the STK11 exons 2–3 deletion carriers
| Patient | Gender | Age at diagnosis | Pigmentation | Hamartomatous polyps | Polyps localization | Cancer |
|---|---|---|---|---|---|---|
| Our study | F | 21 | Yes | Yes | Stomach, small intestine, colon | No |
| Chile [ | F | 34 | Yes | Yes | Small intestine, colon | No |
| Italy II [ | M | 4 | Yes | Yes | Stomach, small intestine, colon | No |
| Italy II [ | M | 1 | No | Yes | Stomach, small intestine, colon | No |
| Italy I [ | N/A | 5 | Yes | Yes | Intestine | N/A |
| Hungary [ | F | 29 | Yes | Yes | Small intestine | N/A |
| Germany [ | N/A | N/A | Yes | Yes | N/A | N/A |
| Korea [ | N/A | N/A | N/A | Yes | N/A | N/A |
| UK [ | M | 15 | N/A | N/A | N/A | No |
| Netherlands [ | N/A | N/A | N/A | Yes | Intestine, nasal cavity | N/A |
| Australia [ | F | 13 | Yes | Yes | N/A | N/A |
| Australia [ | F | 35 | Yes | Yes | N/A | N/A |
N/A data not available, F female, M male
Fig. 2Possible CNV formation based on Alu-mediated homologous recombination model. a STK11 gene structure, b recombination event between two homologous Alu sequences and c gene structure after recombination
Fig. 3Approximate location of other CNVs with breakpoints present in the Alu elements of interest. Mutation order corresponds to the description in Table 2